HEB - Hemispherx Biopharma, Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Net Income-9,813-8,259-7,502-15,230
Operating Activities, Cash Flows Provided By or Used In
Depreciation8371,0041,169975
Adjustments To Net Income150-1,856-1,076774
Changes In Accounts Receivables-1,070-24-24-24
Changes In Liabilities166566-326-196
Changes In Inventories----1,326
Changes In Other Operating Activities-1,173591355-1,050
Total Cash Flow From Operating Activities-10,640-7,941-7,380-16,053
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditure-51-20-160-240
Investments-8312,7993,3706,842
Other Cash flows from Investing Activities----
Total Cash Flows From Investing Activities922,7302,9166,352
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid----
Sale Purchase of Stock----
Net Borrowings4,9181,900-1-21
Other Cash Flows from Financing Activities-553-1021414
Total Cash Flows From Financing Activities9,4354,2154,7579,660
Effect Of Exchange Rate Changes----
Change In Cash and Cash Equivalents-1,113-996293-41